Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Neurology (clinical),Neurology
Reference7 articles.
1. Guan W , Ni Z , Hu Y , et al . Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med Epub 2020 Feb 28.
2. Infection risks among patients with multiple sclerosis treated with fingolimod, natalizumab, rituximab, and injectable therapies;Luna;JAMA Neurol,2020
3. Bernheim A , Mei X , Huang M , et al . Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology Epub 2020 Feb 20.
4. The COVID-19 pandemic and the use of MS disease-modifying therapies;Giovannoni;Mult Scler Relat Disord,2019
5. Fingolimod rebound: a review of the clinical experience and management considerations;Barry;Neurol Ther,2019
Cited by
64 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献